Nanotechnology Commercial Organizations – Directory
Showing results 1 - 15 of 22 for nanotechnology companies in Sweden:
Ångström Aerospace Corporation mission is to develop and provide products, including services based on state-of-the-art Micro-ElectroMechanical Systems (MEMS) and nanotechnologies. Using advanced 3-dimensional wafer level packaging, Ångström Aerospace enables 3D-System-in-Package modules that enables unprecedented possibilities to combine micro-electronics and MEMS sensors/actuators.
Acreo provides contract R&D services in electronics, optics and communication technologies. The companies competencies include advance nanoscale fabrication technologies such as nanoimprint lithography.
Attana AB develops and sells biosensors for analysis of biomolecular interactions. Attana's biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Biolin Scientific is an analytical instruments provider, focused on the nanoscale study of interfaces.
Camurus specializes in the development of pharmaceuticals based on advanced and effective innovative nanoscale drug delivery systems that optimize the bioavailability and therapeutic performance of a wide range of difficult substances, including: peptides, proteins, and insoluble small molecules.
The company develops electrochromic products that save energy and increase comfort levels. Their patented technologies enable production of plastic foils with controllable optical characteristics - they become lighter or darker by applying a low electrical voltage.
The company develops and sells tools for biomedical research based on nanotechnologies. Our products range from nanoparticles in suspensions to engineered surfaces for applications within stem cell research.
Eka Chemicals is one of the world's leading manufacturers of bleaching and performance chemicals for the pulp and paper industry and supplies colloidal silicas in grades ranging from five to 100 nanometers with varying pH, concentration or charge. The company is a business unit within Akzo Nobel.
Genovis has a broad knowledge within physics, biology and biochemistry and offers nanoparticles as tools in medical imaging and for in vitro/in vivo transfections. We have developed a new category of nanoparticles that generate a contrast effect in more than one type of medical imaging technique and offer customer made nanoparticles which besides the particles per se also include method development and services in the form of pre-studies that are specifically adapted to the individual needs of the customer.
glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.
Graphensic AB produces and supplies epitaxial graphene on silicon carbide. The graphene products are manufactured using the High Temperature Graphene Process.
Graphmatech is a Swedish materials technology startup company that invents, develops and sells novel Graphene-based nanocomposites materials and services.
Nanologica engineers nanoporous materials for use in a range of industries, from pharmaceuticals to petrochemicals. Their patented technique enables them to create structures that have novel properties and functions based on their size, shape or composition that boost efficiency and lower manufacturing costs.
Nanoxis is a biotechnology company with extensive knowledge and experience in membrane protein research. Nanoxis has nanoscale technology solutions based on soft polymer and fluid-state liquid crystalline materials. The company is working on research and development of new nanofabrication technologies in soft polymer and fluid-state liquid crystalline material. These technologies are applicable for production of biochips used in proteomics and genetics and as advanced components for nanofluidics, nanoelectronics and robotics.
Oasmia Pharmaceutical AB develops next generation cancer drugs based on nanotechnology for human and veterinary use.